Related references
Note: Only part of the references are listed.The Diversity of Escherichia coli Pathotypes and Vaccination Strategies against This Versatile Bacterial Pathogen
Pravil Pokharel et al.
MICROORGANISMS (2023)
Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trial
Jessica W. Crothers et al.
VACCINE (2022)
Vaccines for Protecting Infants from Bacterial Causes of Diarrheal Disease
Richard Walker et al.
MICROORGANISMS (2021)
Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial
Firdausi Qadri et al.
LANCET INFECTIOUS DISEASES (2020)
Comparison of purified psoralen-inactivated and formalin-inactivated dengue vaccines in mice and nonhuman primates
Appavu K. Sundaram et al.
VACCINE (2020)
Hydrogen peroxide-inactivated bacteria induces potent humoral and cellular immune responses and releases nucleic acids
Yingzi Fan et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Conservation and global distribution of non-canonical antigens in Enterotoxigenic Escherichia coli
F. Matthew Kuhlmann et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses
Marjahan Akhtar et al.
VACCINE (2019)
Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development
Subhra Chakraborty et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Characterization of killed but metabolically active uropathogenic Escherichia coli strain as possible vaccine candidate for urinary tract infection
Zahra Jalili et al.
MICROBIAL PATHOGENESIS (2018)
Killed but metabolically active Pseudomonas aeruginosa-based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections
Elodie Meynet et al.
VACCINE (2018)
Limited Capacity or Involvement of Excision Repair, Double-Strand Breaks, or Translesion Synthesis for Psoralen Cross-Link Repair in Escherichia coli
Jessica M. Cole et al.
GENETICS (2018)
The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
John D. Clements et al.
MSPHERE (2018)
Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin
Qingwei Luo et al.
CLINICAL AND VACCINE IMMUNOLOGY (2016)
Status of vaccine research and development for enterotoxigenic Escherichia coli
A. Louis Bourgeois et al.
VACCINE (2016)
Immunization with the MipA, Skp, or ETEC_2479 Antigens Confers Protection against Enterotoxigenic E. coli Strains Expressing Different Colonization Factorsina Mouse Pulmonary Challenge Model
Michael P. Hays et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2016)
Psoralen Inactivation of Viruses: A Process for the Safe Manipulation of Viral Antigen and Nucleic Acid
Katherine Schneider et al.
VIRUSES-BASEL (2015)
Protective Enterotoxigenic Escherichia coli Antigens in a Murine Intranasal Challenge Model
Amit Kumar et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)
James A. Platts-Mills et al.
LANCET GLOBAL HEALTH (2015)
Development and Preclinical Evaluation of a Trivalent, Formalin-Inactivated Shigella Whole-Cell Vaccine
R. W. Kaminski et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Novel antigens for enterotoxigenic Escherichia coli vaccines
James Fleckenstein et al.
EXPERT REVIEW OF VACCINES (2014)
EatA, an Immunogenic Protective Antigen of Enterotoxigenic Escherichia coli, Degrades Intestinal Mucin
Pardeep Kumar et al.
INFECTION AND IMMUNITY (2014)
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study
Karen L. Kotloff et al.
LANCET (2013)
A Safe Bacterial Microsyringe for In Vivo Antigen Delivery and Immunotherapy
Audrey Le Gouellec et al.
MOLECULAR THERAPY (2013)
Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant
J. Holmgren et al.
VACCINE (2013)
Dengue virus photo-inactivated in presence of 1,5-iodonaphthylazide (INA) or AMT, a psoralen compound (4′-aminomethyl-trioxsalen) is highly immunogenic in mice
Kanakatte Raviprakash et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Cooperative Role of Antibodies against Heat-Labile Toxin and the EtpA Adhesin in Preventing Toxin Delivery and Intestinal Colonization by Enterotoxigenic Escherichia coli
Koushik Roy et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Killed but metabolically active vaccines
Thomas W. Dubensky et al.
CURRENT OPINION IN BIOTECHNOLOGY (2012)
Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges
Iris Delrue et al.
EXPERT REVIEW OF VACCINES (2012)
Characterization of a Mutant Escherichia coli Heat-Labile Toxin, LT(R192G/L211A), as a Safe and Effective Oral Adjuvant
Elizabeth B. Norton et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Immunogenicity and protective efficacy of a psoralen-inactivated dengue-1 virus vaccine candidate in Aotus nancymaae monkeys
Ryan C. Maves et al.
VACCINE (2011)
A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC)
Chad K. Porter et al.
VACCINE (2011)
Autodisplay of 60-kDa Ro/SS-A antigen and development of a surface display enzyme-linked immunosorbent assay for systemic lupus erythematosus patient sera screening
Klaudia Petermann et al.
ANALYTICAL BIOCHEMISTRY (2010)
Construction and expression of immunogenic hybrid enterotoxigenic Escherichia coli CFA/I and CS2 colonization fimbriae for use in vaccines
Joshua Tobias et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2010)
Immunogenicity of a Psoralen-Inactivated Dengue Virus Type 1 Vaccine Candidate in Mice
Ryan C. Maves et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Killed but Metabolically Active Bacillus anthracis Vaccines Induce Broad and Protective Immunity against Anthrax
Justin Skoble et al.
INFECTION AND IMMUNITY (2009)
The EtpA exoprotein of enterotoxigenic Escherichia coli promotes intestinal colonization and is a protective antigen in an experimental model of murine infection
Koushik Roy et al.
INFECTION AND IMMUNITY (2008)
Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains
Yoshio Tano et al.
VACCINE (2007)
Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh
Firdausi Qadri et al.
INFECTION AND IMMUNITY (2007)
Killed but metabolically active Salmonella typhimurium:: Application of a new technology to an old vector
Alexander J. Lankowski et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity
DG Brockstedt et al.
NATURE MEDICINE (2005)
Bacterial surface association of heat-labile enterotoxin through lipopolysaccharide after secretion via the general secretory pathway
AL Horstman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulation of nucleotide excision repair in bacteria and mammalian cells
PC Hanawalt et al.
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY (2000)
Share Paper
